Krish Ramadurai

Krish is a graduate student at St. Catherine’s College (MSc), St. Hilda’s College (DPhil), and a member of the Multimodal Medical Data Integration & Analysis (MultiMeDIA) Group at the Institute of Biomedical Engineering (IBME). His research has been focused on predictive in silico modeling of nanomedicines and Drug Development Digital Twins (D3Ts) to accelerate the clinical translatability of next-generation therapeutics. Furthermore, he is a Partner at AIX Ventures, leading the firm’s technical due diligence, investment sourcing, and portfolio operational support across their AI-enabled healthcare and life sciences practices. He has backed over 20 major scientific breakthroughs spanning the world’s first AI-designed drug in human trials and the first drug discovered through a 3D bioprinted tissue disease model.

Furthermore, he is a Harvard & Oxford-trained scientist and bioengineer, multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked at the Belfer Center for Science and International Affairs with former United States Secretary of Defense Ash Carter and Nobel Laureate Economist Michael Kremer on the United States Agency for International Development (USAID) Development Innovation Ventures Fund. He published three internationally-released books on applied engineering and medicine featured in Barnes & Noble and the Oxford, MIT, Harvard, Yale, and Princeton library collections. His graduate thesis work focused on 3D bioprinting with novel biopolymers for surgical instrument fabrication. He has held chairman and board positions for multiple companies, is a venture advisor for Nucleate and the National Venture Capital Association (NVCA) Venture Forward Program, and is a member of the American Society of Biomechanics and the American Institute of Chemical Engineers.

His thought leadership on AI-enabled life sciences, healthcare, and technology has been featured in leading media outlets, including the Wall Street Journal, Venture Capital Journal, Yahoo Finance, NBC, World Economic Forum, Economy Middle East, TechBullion, Apple Podcasts, Funds Europe Magazine, Pulse 2.0, and Nikkei Asia. He earned dual master’s degrees in biology and business administration from Harvard University and Washington University in St. Louis, respectively, and a bachelor’s degree in integrative biology and economics with a chemistry minor from the University of Illinois at Urbana-Champaign.

• AI Drug Discovery and Development

• Kremer, M., Gallant, S., Rostapshova, O. and Thomas, M., 2021. Is Development Economics a Good Investment? Evidence on scaling rate and social returns from USAID’s innovation fund. Harvard University.
• Bhatia, S.K. and Ramadurai, K.W., 2017. 3D printing and bio-based materials in global health. Switzerland: Springer International Publishing AG.
• Ramadurai, K.W. and Bhatia, S.K., 2018. Reimagining Innovation in Humanitarian Medicine: Engineering Care to Improve Health and Welfare. Springer.
• Tracy, A.A., Bhatia, S.K. and Ramadurai, K.W., 2018. Bio-based materials as applicable, accessible, and affordable healthcare solutions. Springer.

Guest Lecturer, Harvard University:

• Tissue Engineering for Clinical Applications
• Biochemical Engineering & Synthetic Life
• Biomedical Product Development